Goal Reached Thanks to every supporter — we hit 100%!

Goal: 1000 CNY · Raised: 1000 CNY

100.0%
Get alerts for future matching vulnerabilitiesLog in to subscribe
I. Basic Information for CVE-2021-41930
Vulnerability Information

Have questions about the vulnerability? See if Shenlong's analysis helps!
View Shenlong Deep Dive ↗

Although we use advanced large model technology, its output may still contain inaccurate or outdated information.Shenlong tries to ensure data accuracy, but please verify and judge based on the actual situation.

Vulnerability Title
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Description
Cross site scripting (XSS) vulnerability in Sourcecodester Online Covid Vaccination Scheduler System v1 by oretnom23, allows attackers to execute arbitrary code via the lid parameter to /scheduler/addSchedule.php.
Source: NVD (National Vulnerability Database)
CVSS Information
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Type
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Title
SourceCodester Online Covid Vaccination Scheduler System 跨站脚本漏洞
Source: CNNVD (China National Vulnerability Database)
Vulnerability Description
SourceCodester Online Covid Vaccination Scheduler System是SourceCodester公司的一个应用系统。通过可靠的疫苗计划和队列管理解决方案有效管理 COVID-19 疫苗接种。 Sourcecodester Online Covid vaccine Scheduler System v1版本存在跨站脚本漏洞,该漏洞源于软件lid参数缺少对于用户数据的转义或过滤,这允许攻击者可利用该漏洞通过 /scheduler/addSchedule.php的l
Source: CNNVD (China National Vulnerability Database)
CVSS Information
N/A
Source: CNNVD (China National Vulnerability Database)
Vulnerability Type
N/A
Source: CNNVD (China National Vulnerability Database)
Affected Products
VendorProductAffected VersionsCPESubscribe
-n/a n/a -
II. Public POCs for CVE-2021-41930
#POC DescriptionSource LinkShenlong Link
AI-Generated POCPremium

No public POC found.

Login to generate AI POC
III. Intelligence Information for CVE-2021-41930
Please Login to view more intelligence information
IV. Related Vulnerabilities
V. Comments for CVE-2021-41930

No comments yet


Leave a comment